Cytotoxicity and activation of the Wnt/beta-catenin pathway in mouse embryonic stem cells treated with four GSK3 inhibitors

BMC Research Notes

Volumn 7, Issue 1, 2014, Pages

  Naujok, Ortwin ^a   Lentes, Jana ^a   Diekmann, Ulf ^a   Davenport, Claudia ^a   Lenzen, Sigurd ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; 6 [[2 [[4 (2,4 DICHLOROPHENYL) 5 (4 METHYL 1H IMIDAZOL 2 YL) 2 PYRIMIDINYL]AMINO]ETHYL]AMINO]NICOTINONITRILE; AMINOPYRIDINE DERIVATIVE; BRACHYURY PROTEIN; CHIR 98014; FETOPROTEIN; GLYCOGEN SYNTHASE KINASE 3; INDOLE DERIVATIVE; MALEIMIDE DERIVATIVE; OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, MOUSE; PROTEIN KINASE INHIBITOR; PYRIDINE DERIVATIVE; PYRIMIDINE DERIVATIVE; T BOX TRANSCRIPTION FACTOR;

ANIMAL; ANTAGONISTS AND INHIBITORS; CELL DEATH; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; CYTOLOGY; DRUG EFFECTS; EMBRYONIC STEM CELL; ENZYMOLOGY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MOUSE; TOXICITY; WNT SIGNALING PATHWAY;

AMINOPYRIDINES; ANIMALS; CELL DEATH; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; EMBRYONIC STEM CELLS; FETAL PROTEINS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; INDOLES; MALEIMIDES; MICE; OCTAMER TRANSCRIPTION FACTOR-3; PROTEIN KINASE INHIBITORS; PYRIDINES; PYRIMIDINES; T-BOX DOMAIN PROTEINS; WNT SIGNALING PATHWAY;

EID: 84899728367     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-7-273     Document Type: Article

References (33)

1. Involvement of GSK-3 in regulation of murine embryonic stem cell self-renewal revealed by a series of bisindolylmaleimides. Bone HK, Damiano T, Bartlett S, Perry A, Letchford J, Ripoll YS, Nelson AS, Welham MJ, Chem Biol 2009 16 15 27 10.1016/j.chembiol.2008.11.003 19171302
2. Pleiotropy of glycogen synthase kinase-3 inhibition by CHIR99021 promotes self-renewal of embryonic stem cells from refractory mouse strains. Ye S, Tan L, Yang R, Fang B, Qu S, Schulze EN, Song H, Ying Q, Li P, PloS one 2012 7 35892 10.1371/journal.pone.0035892 22540008
3. Glycogen synthase kinase 3 (GSK3) inhibitor, SB-216763, promotes pluripotency in mouse embryonic stem cells. Kirby LA, Schott JT, Noble BL, Mendez DC, Caseley PS, Peterson SC, Routledge TJ, Patel NV, PloS one 2012 7 39329 10.1371/journal.pone.0039329 22745733
4. Glycogen synthase kinase-3 inhibition enhances translation of pluripotency-associated transcription factors to contribute to maintenance of mouse embryonic stem cell self-renewal. Sanchez-Ripoll Y, Bone HK, Owen T, Guedes AM, Abranches E, Kumpfmueller B, Spriggs RV, Henrique D, Welham MJ, PloS one 2013 8 60148 10.1371/journal.pone.0060148 23577087
5. Germline competent embryonic stem cells derived from rat blastocysts. Li P, Tong C, Mehrian-Shai R, Jia L, Wu N, Yan Y, Maxson RE, Schulze EN, Song H, Hsieh CL, Pera MF, Ying QL, Cell 2008 135 1299 1310 10.1016/j.cell.2008.12.006 19109898
6. Validated germline-competent embryonic stem cell lines from nonobese diabetic mice. Nichols J, Jones K, Phillips JM, Newland SA, Roode M, Mansfield W, Smith A, Cooke A, Nat Med 2009 15 814 818 10.1038/nm.1996 19491843
7. A small molecule that directs differentiation of human ESCs into the pancreatic lineage. Chen S, Borowiak M, Fox JL, Maehr R, Osafune K, Davidow L, Lam K, Peng LF, Schreiber SL, Rubin LL, Melton D, Nat Chem Biol 2009 5 258 265 10.1038/nchembio.154 19287398
8. A small molecule primes embryonic stem cells for differentiation. Zhu S, Wurdak H, Wang J, Lyssiotis CA, Peters EC, Cho CY, Wu X, Schultz PG, Cell stem cell 2009 4 416 426 10.1016/j.stem.2009.04.001 19427291
9. Small molecules efficiently direct endodermal differentiation of mouse and human embryonic stem cells. Borowiak M, Maehr R, Chen S, Chen AE, Tang W, Fox JL, Schreiber SL, Melton DA, Cell stem cell 2009 4 348 358 10.1016/j.stem.2009.01.014 19341624
10. A critical re-evaluation of CD24-positivity of human embryonic stem cells differentiated into pancreatic progenitors. Naujok O, Lenzen S, Stem Cell Rev 2012 8 779 791 10.1007/s12015-012-9362-y 22529013
11. Small molecules in stem cell research. Schmole AC, Hubner R, Beller M, Rolfs A, Frech MJ, Curr Pharm Biotechnol 2013 14 36 45 23092256
12. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. D'Amour KA, Bang AG, Eliazer S, Kelly OG, Agulnick AD, Smart NG, Moorman MA, Kroon E, Carpenter MK, Baetge EE, Nat Biotechnol 2006 24 1392 1401 10.1038/nbt1259 17053790
13. Noggin, retinoids, and fibroblast growth factor regulate hepatic or pancreatic fate of human embryonic stem cells. Mfopou JK, Chen B, Mateizel I, Sermon K, Bouwens L, Gastroenterology 2010 138 2233 2245 10.1053/j.gastro.2010. 02.056 20206178
14. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Kroon E, Martinson LA, Kadoya K, Bang AG, Kelly OG, Eliazer S, Young H, Richardson M, Smart NG, Cunningham J, Agulnick AD, D'Amour KA, Carpenter MK, Baetge EE, Nat Biotechnol 2008 26 443 452 10.1038/nbt1393 18288110
15. Efficient derivation of lateral plate and paraxial mesoderm subtypes from human embryonic stem cells through GSKi-mediated differentiation. Tan JY, Sriram G, Rufaihah AJ, Neoh KG, Cao T, Stem Cells Dev 2013 22 1893 1906 10.1089/scd.2012.0590 23413973
16. Signaling pathways during maintenance and definitive endoderm differentiation of embryonic stem cells. Sui L, Bouwens L, Mfopou JK, Int J Dev Biol 2013 57 1 12 10.1387/ijdb.120115ls 23585347
17. Wnt signaling in stem and cancer stem cells. Holland JD, Klaus A, Garratt AN, Birchmeier W, Curr Opin Cell Biol 2013 25 254 264 10.1016/j.ceb.2013.01.004 23347562
18. GSK-3: tricks of the trade for a multi-tasking kinase. Doble BW, Woodgett JR, J Cell Sci 2003 116 1175 1186 10.1242/jcs.00384 12615961
19. The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. Doetschman TC, Eistetter H, Katz M, Schmidt W, Kemler R, J Embryol Exp Morphol 1985 87 27 45 3897439
20. Germ-line transmission of genes introduced into cultured pluripotential cells by retroviral vector. Robertson E, Bradley A, Kuehn M, Evans M, Nature 1986 323 445 448 10.1038/323445a0 3762693
21. MicroRNA target sites as genetic tools to enhance promoter-reporter specificity for the purification of pancreatic progenitor cells from differentiated embryonic stem cells. Diekmann U, Elsner M, Fiedler J, Thum T, Lenzen S, Naujok O, Stem Cell Rev 2013 9 555 568 10.1007/s12015-012-9416-1 23111459
22. Selective removal of undifferentiated embryonic stem cells from differentiation cultures through HSV1 thymidine kinase and ganciclovir treatment. Naujok O, Kaldrack J, Taivankhuu T, Jörns A, Lenzen S, Stem Cell Rev 2010 6 450 461 10.1007/s12015-010-9148-z 20411442
23. Zebrafish prickle, a modulator of noncanonical Wnt/Fz signaling, regulates gastrulation movements. Veeman MT, Slusarski DC, Kaykas A, Louie SH, Moon RT, Curr Biol 2003 13 680 685 10.1016/S0960-9822(03)00240-9 12699626
24. Brachyury is a target gene of the Wnt/beta-catenin signaling pathway. Arnold SJ, Stappert J, Bauer A, Kispert A, Herrmann BG, Kemler R, Mech Dev 2000 91 249 258 10.1016/S0925-4773(99)00309-3 10704849
25. A novel chemically directed route for the generation of definitive endoderm from human embryonic stem cells based on inhibition of GSK-3. Bone HK, Nelson AS, Goldring CE, Tosh D, Welham MJ, J Cell Sci 2011 124 1992 2000 10.1242/jcs.081679 21610099
26. Stable generation of serum- and feeder-free embryonic stem cell-derived mice with full germline-competency by using a GSK3 specific inhibitor. Sato H, Amagai K, Shimizukawa R, Tamai Y, Genesis 2009 47 414 422 10.1002/dvg.20514 19391115
27. Expression of nodal, lefty-a, and lefty-B in undifferentiated human embryonic stem cells requires activation of Smad2/3. Besser D, J Biol Chem 2004 279 45076 45084 10.1074/jbc.M404979200 15308665
28. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Sato N, Meijer L, Skaltsounis L, Greengard P, Brivanlou AH, Nat Med 2004 10 55 63 10.1038/nm979 14702635
29. The selectivity of protein kinase inhibitors: a further update. Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, Klevernic I, Arthur JS, Alessi DR, Cohen P, Biochem J 2007 408 297 315 10.1042/BJ20070797 17850214
30. Functional redundancy of GSK-3alpha and GSK-3beta in Wnt/beta-catenin signaling shown by using an allelic series of embryonic stem cell lines. Doble BW, Patel S, Wood GA, Kockeritz LK, Woodgett JR, Dev Cell 2007 12 957 971 10.1016/j.devcel.2007.04.001 17543867
31. Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation. Wray J, Kalkan T, Gomez-Lopez S, Eckardt D, Cook A, Kemler R, Smith A, Nat Cell Biol 2011 13 838 845 10.1038/ncb2267 21685889
32. The ground state of embryonic stem cell self-renewal. Ying QL, Wray J, Nichols J, Batlle-Morera L, Doble B, Woodgett J, Cohen P, Smith A, Nature 2008 453 519 523 10.1038/nature06968 18497825
33. Three inhibitors of FGF receptor, ERK, and GSK3 establishes germline-competent embryonic stem cells of C57BL/6 N mouse strain with high efficiency and stability. Kiyonari H, Kaneko M, Abe S, Aizawa S, Genesis 2010 48 317 327 20162675